<!DOCTYPE html><html lang="en-us" >


<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  
  
  
    <meta name="generator" content="Wowchemy 5.6.0 for Hugo" />
  

  
  












  
  










  







  
  
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin />
  

  
  
  
    
      
      <link rel="preload" as="style" href="https://fonts.googleapis.com/css2?family=Montserrat:wght@400;700&family=Roboto+Mono&family=Roboto:wght@400;700&display=swap">
      <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Montserrat:wght@400;700&family=Roboto+Mono&family=Roboto:wght@400;700&display=swap" media="print" onload="this.media='all'">
    
  

  
  
  
  
  
    
    
    
  
  

  <meta name="author" content="Vlad Popovici" />

  
  
  
    
  
  <meta name="description" content="Stage II colon cancer (CC) encompasses a heterogeneous group of patients with diverse survival experiences: 87% to 58% 5-year relative survival rates for stages IIA and IIC, respectively. While stage IIA patients are usually spared the adjuvant chemotherapy, some of them relapse and may benefit from it; thus, their timely identification is crucial. Current gene expression signatures did not specifically target this group nor did they find their place in clinical practice. Since processes at invasion front have also been linked to tumor progression, we hypothesize that aside from bulk tumor features, focusing on the invasion front may provide additional clues for this stratification. A retrospective matched case-control collection of 39 stage IIA microsatellite-stable (MSS) untreated CCs was analyzed to identify prognostic gene expression-based signatures. The endpoint was defined as relapse within 5 years vs. no relapse for at least 6 years. From the same tumors, three different classifiers (bulk tumor, invasion front, and constrained baseline on bulk tumor) were developed and their performance estimated. The baseline classifier, while the weakest, was validated in two independent data sets. The best performing signature was based on invasion front profiles [area under the receiver operating curve (AUC) = 0.931 (0.815–1.0)] and contained genes associated with KRAS pathway activation, apical junction complex, and heme metabolism. Its combination with bulk tumor classifier further improved the accuracy of the predictions." />

  
  <link rel="alternate" hreflang="en-us" href="https://bioinfo-recetox.github.io/publication/2024-frontonc/" />

  
  
  
    <meta name="theme-color" content="#3f51b5" />
  

  
  

  

  <link rel="stylesheet" href="/css/vendor-bundle.min.c7b8d9abd591ba2253ea42747e3ac3f5.css" media="print" onload="this.media='all'">

  
  
  
    
    
      <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/academicons@1.9.1/css/academicons.min.css" integrity="sha512-W0xM4mr6dEP9nREo7Z9z+9X70wytKvMGeDsj7ps2+xg5QPrEBXC8tAW1IFnzjR6eoJ90JmCnFzerQJTLzIEHjA==" crossorigin="anonymous" media="print" onload="this.media='all'">
    

    
    
    
    
      
      
    
    
    

    
    
    
      <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/leaflet@1.7.1/dist/leaflet.min.css" integrity="" crossorigin="anonymous" media="print" onload="this.media='all'">
    

    

    
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      
        
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
  

  
  
  
  
  
  
  <link rel="stylesheet" href="/css/wowchemy.47f3fb8fc1366a63625e60f327964c02.css" />

  
  
  
  
  
  
  
    
    
    <link rel="stylesheet" href="/css/libs/chroma/github-light.min.css" title="hl-light" media="print" onload="this.media='all'" >
    <link rel="stylesheet" href="/css/libs/chroma/dracula.min.css" title="hl-dark" media="print" onload="this.media='all'" disabled>
  

  
  



  


  


  




  
  
  

  
  

  
  
    <link rel="manifest" href="/manifest.webmanifest" />
  

  
  <link rel="icon" type="image/png" href="/media/icon_hub5cd333a9ad2ed2c4484e85fbbb63248_94796_32x32_fill_lanczos_center_3.png" />
  <link rel="apple-touch-icon" type="image/png" href="/media/icon_hub5cd333a9ad2ed2c4484e85fbbb63248_94796_180x180_fill_lanczos_center_3.png" />

  <link rel="canonical" href="https://bioinfo-recetox.github.io/publication/2024-frontonc/" />

  
  
  
  
  
  
  
  
    
  
  

  
  
    
    
  
  <meta property="twitter:card" content="summary_large_image" />
  
  <meta property="og:site_name" content="IB2: Integrative Bioinformatics and Biostatistics" />
  <meta property="og:url" content="https://bioinfo-recetox.github.io/publication/2024-frontonc/" />
  <meta property="og:title" content="An invasion front gene expression signature for higher-risk patient selection in stage IIA MSS colon cancer | IB2: Integrative Bioinformatics and Biostatistics" />
  <meta property="og:description" content="Stage II colon cancer (CC) encompasses a heterogeneous group of patients with diverse survival experiences: 87% to 58% 5-year relative survival rates for stages IIA and IIC, respectively. While stage IIA patients are usually spared the adjuvant chemotherapy, some of them relapse and may benefit from it; thus, their timely identification is crucial. Current gene expression signatures did not specifically target this group nor did they find their place in clinical practice. Since processes at invasion front have also been linked to tumor progression, we hypothesize that aside from bulk tumor features, focusing on the invasion front may provide additional clues for this stratification. A retrospective matched case-control collection of 39 stage IIA microsatellite-stable (MSS) untreated CCs was analyzed to identify prognostic gene expression-based signatures. The endpoint was defined as relapse within 5 years vs. no relapse for at least 6 years. From the same tumors, three different classifiers (bulk tumor, invasion front, and constrained baseline on bulk tumor) were developed and their performance estimated. The baseline classifier, while the weakest, was validated in two independent data sets. The best performing signature was based on invasion front profiles [area under the receiver operating curve (AUC) = 0.931 (0.815–1.0)] and contained genes associated with KRAS pathway activation, apical junction complex, and heme metabolism. Its combination with bulk tumor classifier further improved the accuracy of the predictions." /><meta property="og:image" content="https://bioinfo-recetox.github.io/publication/2024-frontonc/featured.jpg" />
    <meta property="twitter:image" content="https://bioinfo-recetox.github.io/publication/2024-frontonc/featured.jpg" /><meta property="og:locale" content="en-us" />
  
    
      <meta
        property="article:published_time"
        content="2024-04-19T00:00:00&#43;00:00"
      />
    
    <meta property="article:modified_time" content="2024-04-19T00:00:00&#43;00:00">
  

  


    









<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "Article",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://bioinfo-recetox.github.io/publication/2024-frontonc/"
  },
  "headline": "An invasion front gene expression signature for higher-risk patient selection in stage IIA MSS colon cancer",
  
  "image": [
    "https://bioinfo-recetox.github.io/publication/2024-frontonc/featured.jpg"
  ],
  
  "datePublished": "2024-04-19T00:00:00Z",
  "dateModified": "2024-04-19T00:00:00Z",
  
  "author": {
    "@type": "Person",
    "name": "Eva Budinská"
  },
  
  "publisher": {
    "@type": "Organization",
    "name": "RECETOX",
    "logo": {
      "@type": "ImageObject",
      "url": "https://bioinfo-recetox.github.io/media/icon_hub5cd333a9ad2ed2c4484e85fbbb63248_94796_192x192_fill_lanczos_center_3.png"
    }
  },
  "description": "Stage II colon cancer (CC) encompasses a heterogeneous group of patients with diverse survival experiences: 87% to 58% 5-year relative survival rates for stages IIA and IIC, respectively. While stage IIA patients are usually spared the adjuvant chemotherapy, some of them relapse and may benefit from it; thus, their timely identification is crucial. Current gene expression signatures did not specifically target this group nor did they find their place in clinical practice. Since processes at invasion front have also been linked to tumor progression, we hypothesize that aside from bulk tumor features, focusing on the invasion front may provide additional clues for this stratification. A retrospective matched case-control collection of 39 stage IIA microsatellite-stable (MSS) untreated CCs was analyzed to identify prognostic gene expression-based signatures. The endpoint was defined as relapse within 5 years vs. no relapse for at least 6 years. From the same tumors, three different classifiers (bulk tumor, invasion front, and constrained baseline on bulk tumor) were developed and their performance estimated. The baseline classifier, while the weakest, was validated in two independent data sets. The best performing signature was based on invasion front profiles [area under the receiver operating curve (AUC) = 0.931 (0.815–1.0)] and contained genes associated with KRAS pathway activation, apical junction complex, and heme metabolism. Its combination with bulk tumor classifier further improved the accuracy of the predictions."
}
</script>

  

  

  


  <title>An invasion front gene expression signature for higher-risk patient selection in stage IIA MSS colon cancer | IB2: Integrative Bioinformatics and Biostatistics</title>

  
  
  
  











</head>


<body id="top" data-spy="scroll" data-offset="70" data-target="#TableOfContents" class="page-wrapper   " data-wc-page-id="51820191436a181f0924e78330e81cb0" >

  
  
  
  
  
  
  
  
  
  <script src="/js/wowchemy-init.min.1ee5462d74c6c0de1f8881b384ecc58d.js"></script>

  


<aside class="search-modal" id="search">
  <div class="container">
    <section class="search-header">

      <div class="row no-gutters justify-content-between mb-3">
        <div class="col-6">
          <h1>Search</h1>
        </div>
        <div class="col-6 col-search-close">
          <a class="js-search" href="#" aria-label="Close"><i class="fas fa-times-circle text-muted" aria-hidden="true"></i></a>
        </div>
      </div>

      <div id="search-box">
        
        <input name="q" id="search-query" placeholder="Search..." autocapitalize="off"
        autocomplete="off" autocorrect="off" spellcheck="false" type="search" class="form-control"
        aria-label="Search...">
        
      </div>

      
      

      

    </section>
    <section class="section-search-results">

      <div id="search-hits">
        
      </div>

    </section>
  </div>
</aside>



  <div class="page-header">
    












<header class="header--fixed">
  <nav class="navbar navbar-expand-lg navbar-light compensate-for-scrollbar" id="navbar-main">
    <div class="container-xl">

      
      <div class="d-none d-lg-inline-flex">
        <a class="navbar-brand" href="/">IB2: Integrative Bioinformatics and Biostatistics</a>
      </div>
      

      
      <button type="button" class="navbar-toggler" data-toggle="collapse"
              data-target="#navbar-content" aria-controls="navbar-content" aria-expanded="false" aria-label="Toggle navigation">
      <span><i class="fas fa-bars"></i></span>
      </button>
      

      
      <div class="navbar-brand-mobile-wrapper d-inline-flex d-lg-none">
        <a class="navbar-brand" href="/">IB2: Integrative Bioinformatics and Biostatistics</a>
      </div>
      

      
      
      <div class="navbar-collapse main-menu-item collapse justify-content-end" id="navbar-content">

        
        <ul class="navbar-nav d-md-inline-flex">
          

          

          
          
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="/post"><span>News</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="/projects"><span>Projects</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="/people"><span>People</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="/downloads"><span>Downloads</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="/publication"><span>Publications</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="/contact"><span>Contact</span></a>
          </li>

          
          

        

          
        </ul>
      </div>

      <ul class="nav-icons navbar-nav flex-row ml-auto d-flex pl-md-2">

        
        
          
        

        
        
        <li class="nav-item">
          <a class="nav-link js-search" href="#" aria-label="Search"><i class="fas fa-search" aria-hidden="true"></i></a>
        </li>
        

        
        
        

        
        

      </ul>

    </div>
  </nav>
</header>


  </div>

  <div class="page-body">
    
    
    

    








<div class="pub">

  





















  
  


<div class="article-container pt-3">
  <h1>An invasion front gene expression signature for higher-risk patient selection in stage IIA MSS colon cancer</h1>

  

  


<div class="article-metadata">

  
  
  
  
  <div>
    

  <span >
      <a href="/author/eva-budinska/">Eva Budinská</a></span>, <span >
      <a href="/author/martina-hrivnakova/">Martina Hrivňáková</a></span>, <span >
      <a href="/author/tina-catela-ivkovic/">Tina Catela Ivkovič</a></span>, <span >
      <a href="/author/tana-machackova/">Tana Machackova</a></span>, <span >
      <a href="/author/marie-boudna/">Marie Boudna</a></span>, <span >
      <a href="/author/lucie-pifkova/">Lucie Pifkova</a></span>, <span >
      <a href="/author/ondrej-slaby/">Ondrej Slabý</a></span>, <span >
      <a href="/author/beatrix-bencsikova/">Beatrix Bencsiková</a></span>, <span >
      <a href="/author/vlad-popovici/">Vlad Popovici</a></span>
  </div>
  
  

  
  <span class="article-date">
    
    
      
    
    April 2024
  </span>
  

  

  

  
  
  
  

  
  

</div>

  




<div class="btn-links mb-3">
  
  








  
    
  



<a class="btn btn-outline-primary btn-page-header" href="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1367231/pdf?isPublishedV2=false" target="_blank" rel="noopener">
  PDF
</a>



<a href="#" class="btn btn-outline-primary btn-page-header js-cite-modal"
        data-filename="/publication/2024-frontonc/cite.bib">
  Cite
</a>





  
  <a class="btn btn-outline-primary btn-page-header" href="/project/azv2019_vp/">
    Project
  </a>
  









<a class="btn btn-outline-primary btn-page-header" href="https://doi.org/10.3389/fonc.2024.1367231%20" target="_blank" rel="noopener">
  DOI
</a>



</div>


</div>


<div class="article-header article-container featured-image-wrapper mt-4 mb-4" style="max-width: 720px; max-height: 579px;">
  <div style="position: relative">
    <img src="/publication/2024-frontonc/featured_hu19713d0eaca645ac851a46c93fc95e70_99544_720x2500_fit_q75_h2_lanczos.webp" width="720" height="579" alt="" class="featured-image">
    <span class="article-header-caption">Prognostic signature</span>
  </div>
</div>



  <div class="article-container">

    
    <h3>Abstract</h3>
    <p class="pub-abstract">Stage II colon cancer (CC) encompasses a heterogeneous group of patients with diverse survival experiences: 87% to 58% 5-year relative survival rates for stages IIA and IIC, respectively. While stage IIA patients are usually spared the adjuvant chemotherapy, some of them relapse and may benefit from it; thus, their timely identification is crucial. Current gene expression signatures did not specifically target this group nor did they find their place in clinical practice. Since processes at invasion front have also been linked to tumor progression, we hypothesize that aside from bulk tumor features, focusing on the invasion front may provide additional clues for this stratification. A retrospective matched case-control collection of 39 stage IIA microsatellite-stable (MSS) untreated CCs was analyzed to identify prognostic gene expression-based signatures. The endpoint was defined as relapse within 5 years vs. no relapse for at least 6 years. From the same tumors, three different classifiers (bulk tumor, invasion front, and constrained baseline on bulk tumor) were developed and their performance estimated. The baseline classifier, while the weakest, was validated in two independent data sets. The best performing signature was based on invasion front profiles [area under the receiver operating curve (AUC) = 0.931 (0.815–1.0)] and contained genes associated with KRAS pathway activation, apical junction complex, and heme metabolism. Its combination with bulk tumor classifier further improved the accuracy of the predictions.</p>
    

    
    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Type</div>
          <div class="col-12 col-md-9">
            <a href="/publication/#2">
              Journal article
            </a>
          </div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Publication</div>
          <div class="col-12 col-md-9"><em>Frontiers in Oncology</em> 14</div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    <div class="space-below"></div>

    <div class="article-style"><!--
<div class="alert alert-note">
  <div>
    Click the <em>Cite</em> button above to demo the feature to enable visitors to import publication metadata into their reference management software.
  </div>
</div>
 -->
</div>

    





<div class="article-tags">
  
  <a class="badge badge-light" href="/tag/crc/">crc</a>
  
  <a class="badge badge-light" href="/tag/biomarkers/">biomarkers</a>
  
  <a class="badge badge-light" href="/tag/azv/">azv</a>
  
</div>



<div class="share-box">
  <ul class="share">
    
      
      
      
        
      
      
      
      <li>
        <a href="mailto:?subject=An%20invasion%20front%20gene%20expression%20signature%20for%20higher-risk%20patient%20selection%20in%20stage%20IIA%20MSS%20colon%20cancer&amp;body=https://bioinfo-recetox.github.io/publication/2024-frontonc/" target="_blank" rel="noopener" class="share-btn-email" aria-label="envelope">
          <i class="fas fa-envelope"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://www.linkedin.com/shareArticle?url=https://bioinfo-recetox.github.io/publication/2024-frontonc/&amp;title=An%20invasion%20front%20gene%20expression%20signature%20for%20higher-risk%20patient%20selection%20in%20stage%20IIA%20MSS%20colon%20cancer" target="_blank" rel="noopener" class="share-btn-linkedin" aria-label="linkedin-in">
          <i class="fab fa-linkedin-in"></i>
        </a>
      </li>
    
  </ul>
</div>











  
  
    



  
  
  
  
  
  <div class="media author-card content-widget-hr">
    
      
      <a href="/author/eva-budinska/"><img class="avatar mr-3 avatar-circle" src="/author/eva-budinska/avatar_hud8eaee7660ad0c038072b8055bd3a3d5_164745_270x270_fill_q75_lanczos_center.jpg" alt="Eva Budinská"></a>
    

    <div class="media-body">
      <h5 class="card-title"><a href="/author/eva-budinska/">Eva Budinská</a></h5>
      <h6 class="card-subtitle">Head of IB2, Assistant Professor of Bioinformatics</h6>
      <p class="card-text">My research interests include metagenomics, multi-omics bioinformatics and translational oncology.</p>
      <ul class="network-icon" aria-hidden="true">
  
    
    
    
      
    
    
    
    
    
    <li>
      <a href="mailto:eva.budinska@recetox.muni.cz" >
        <i class="fas fa-envelope"></i>
      </a>
    </li>
  
    
    
    
    
    
    
    
      
    
    <li>
      <a href="https://scholar.google.com/citations?user=dX1z5OcAAAAJ&amp;hl=en" target="_blank" rel="noopener">
        <i class="ai ai-google-scholar"></i>
      </a>
    </li>
  
</ul>

    </div>
  </div>


  
    



  
  
  
  
  
  <div class="media author-card content-widget-hr">
    
      
      <a href="/author/martina-hrivnakova/"><img class="avatar mr-3 avatar-circle" src="/author/martina-hrivnakova/avatar_hu73d90b24438a9e78ae31c53cd0700fef_171828_270x270_fill_q75_lanczos_center.jpg" alt="Martina Hrivňáková"></a>
    

    <div class="media-body">
      <h5 class="card-title"><a href="/author/martina-hrivnakova/">Martina Hrivňáková</a></h5>
      <h6 class="card-subtitle">PhD student</h6>
      
      <ul class="network-icon" aria-hidden="true">
  
    
    
    
      
    
    
    
    
    
    <li>
      <a href="mailto:anna.pacinkova@recetox.muni.cz" >
        <i class="fas fa-envelope"></i>
      </a>
    </li>
  
</ul>

    </div>
  </div>


  
    




  
    




  
    




  
    




  
    




  
    




  
    



  
  
  
  
  
  <div class="media author-card content-widget-hr">
    
      
      <a href="/author/vlad-popovici/"><img class="avatar mr-3 avatar-circle" src="/author/vlad-popovici/avatar_hu83b78ed1466604b146396f5088cef503_42452_270x270_fill_q75_lanczos_center.jpg" alt="Vlad Popovici"></a>
    

    <div class="media-body">
      <h5 class="card-title"><a href="/author/vlad-popovici/">Vlad Popovici</a></h5>
      <h6 class="card-subtitle">Associate Professor of Computer Science</h6>
      <p class="card-text">My research interests include computational pathology, machine learning and biomarker discovery.</p>
      <ul class="network-icon" aria-hidden="true">
  
    
    
    
      
    
    
    
    
    
    <li>
      <a href="mailto:vlad.popovici@recetox.muni.cz" >
        <i class="fas fa-envelope"></i>
      </a>
    </li>
  
    
    
    
    
    
    
    
      
    
    <li>
      <a href="https://scholar.google.com/citations?user=hLJXAncAAAAJ&amp;hl=en" target="_blank" rel="noopener">
        <i class="ai ai-google-scholar"></i>
      </a>
    </li>
  
    
    
    
      
    
    
    
    
    
      
    
    <li>
      <a href="https://github.com/vladpopovici" target="_blank" rel="noopener">
        <i class="fab fa-github"></i>
      </a>
    </li>
  
</ul>

    </div>
  </div>


  
















  </div>
</div>
  </div>

  <div class="page-footer">
    
    
    <div class="container">
      <footer class="site-footer">

  












  

  

  

  
  






  
  
  

  
  
    
  
  
    
  

  

  
  <p class="powered-by copyright-license-text">
    © 2024 IB2@RECETOX. This work is licensed under <a href="https://creativecommons.org/licenses/by-nc-nd/4.0" rel="noopener noreferrer" target="_blank">CC BY NC ND 4.0</a>
  </p>
  

  <p class="powered-by footer-license-icons">
    <a href="https://creativecommons.org/licenses/by-nc-nd/4.0" rel="noopener noreferrer" target="_blank" aria-label="Creative Commons">
      <i class="fab fa-creative-commons fa-2x" aria-hidden="true"></i>
      <i class="fab fa-creative-commons-by fa-2x" aria-hidden="true"></i>
      
        <i class="fab fa-creative-commons-nc fa-2x" aria-hidden="true"></i>
      
      
        <i class="fab fa-creative-commons-nd fa-2x" aria-hidden="true"></i>
      
    </a>
  </p>




  <p class="powered-by">
    
    
    
      
      
      
      
      
      
      Published with <a href="https://wowchemy.com/?utm_campaign=poweredby" target="_blank" rel="noopener">Wowchemy</a> — the free, <a href="https://github.com/wowchemy/wowchemy-hugo-themes" target="_blank" rel="noopener">open source</a> website builder that empowers creators.
    
  </p>
</footer>

    </div>
    
  </div>

  


<script src="/js/vendor-bundle.min.b4708d4364577c16ab7001b265a063a4.js"></script>




  

  
  

  






  <script src="https://cdn.jsdelivr.net/npm/leaflet@1.7.1/dist/leaflet.min.js" integrity="" crossorigin="anonymous"></script>








  
  <script id="search-hit-fuse-template" type="text/x-template">
    <div class="search-hit" id="summary-{{key}}">
      <div class="search-hit-content">
        <div class="search-hit-name">
          <a href="{{relpermalink}}">{{title}}</a>
          <div class="article-metadata search-hit-type">{{type}}</div>
          <p class="search-hit-description">{{snippet}}</p>
        </div>
      </div>
    </div>
  </script>
  
    <script src="https://cdn.jsdelivr.net/gh/krisk/Fuse@v3.2.1/dist/fuse.min.js" integrity="sha512-o38bmzBGX+hD3JHWUFCDA09btWaqrNmoJ3RXLlrysA7PP01Kgs4UlE4MhelE1v5dJR3+cxlR4qQlotsW7jKsnw==" crossorigin="anonymous"></script>
    <script src="https://cdn.jsdelivr.net/gh/julmot/mark.js@8.11.1/dist/jquery.mark.min.js" integrity="sha512-mhbv5DqBMgrWL+32MmsDOt/OAvqr/cHimk6B8y/bx/xS88MVkYGPiVv2ixKVrkywF2qHplNRUvFsAHUdxZ3Krg==" crossorigin="anonymous"></script>
  












  
  
  
  
  
  
  







<script id="page-data" type="application/json">{"use_headroom":true}</script>



  <script src="/js/wowchemy-headroom.c251366b4128fd5e6b046d4c97a62a51.js" type="module"></script>








  
  


<script src="/en/js/wowchemy.min.42010733157c11a71adebfe9bae43355.js"></script>



  <script src="/js/wowchemy-map.a26e9d2f7238ba5b868384f1c5bc6477.js" type="module"></script>




  
<div id="modal" class="modal fade" role="dialog">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <h5 class="modal-title">Cite</h5>
        <button type="button" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true">&times;</span>
        </button>
      </div>
      <div class="modal-body">
        
        <pre><code></code></pre>
      </div>
      <div class="modal-footer">
        <a class="btn btn-outline-primary my-1 js-copy-cite" href="#" target="_blank">
          <i class="fas fa-copy"></i> Copy
        </a>
        <a class="btn btn-outline-primary my-1 js-download-cite" href="#" target="_blank">
          <i class="fas fa-download"></i> Download
        </a>
        <div id="modal-error"></div>
      </div>
    </div>
  </div>
</div>


  <script src="/js/wowchemy-publication.af9327db0521d4a01354bfc8b77a4324.js" type="module"></script>
















</body>
</html>
